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Objective: Bacterial and viral infectious triggers are linked to spondyloarthritis (SpA)
including psoriatic arthritis (PsA) development, likely via dendritic cell activation. We
investigated spinal entheseal plasmacytoid dendritic cells (pDCs) toll-like receptor (TLR)-
7 and 9 activation and therapeutic modulation, including JAK inhibition. We also
investigated if COVID-19 infection, a potent TLR-7 stimulator triggered PsA flares.
Methods: Normal entheseal pDCs were characterized and stimulated with imiquimod
and CpG oligodeoxynucleotides (ODN) to evaluate TNF and IFNa production. NanoString
gene expression assay of total pDCs RNA was performed pre- and post- ODN
stimulation. Pharmacological inhibition of induced IFNa protein was performed with
Tofacitinib and PDE4 inhibition. The impact of SARS-CoV2 viral infection on PsA flares
was evaluated.
Results: CD45+HLA-DR+CD123+CD303+CD11c- entheseal pDCs were more
numerous than blood pDCs (1.9 ± 0.8% vs 0.2 ± 0.07% of CD45+ cells, p=0.008) and
showed inducible IFNa and TNF protein following ODN/imiquimod stimulation and were
the sole entheseal IFNa producers. NanoString data identified 11 significantly upregulated
differentially expressed genes (DEGs) including TNF in stimulated pDCs. Canonicalorg April 2021 | Volume 12 | Article 6350181
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Frontiers in Immunology | www.frontiersin.pathway analysis revealed activation of dendritic cell maturation, NF-kB signaling, toll-like
receptor signaling and JAK/STAT signaling pathways following ODN stimulation. Both
tofacitinib and PDE4i strongly attenuated ODN induced IFNa. DAPSA scores elevations
occurred in 18 PsA cases with SARS-CoV2 infection (9.7 ± 4 pre-infection and 35.3 ± 7.5
during infection).
Conclusion: Entheseal pDCs link microbes to TNF/IFNa production. SARS-CoV-2
infection is associated with PsA Flares and JAK inhibition suppressed activated
entheseal plasmacytoid dendritic Type-1 interferon responses as pointers towards a
novel mechanism of PsA and SpA-related arthropathy.Keywords: plasmacytoid dendritic cells, interferon alpha, psoriatic arthritis, COVID-19, enthesisINTRODUCTION
Entheses are locations where tendons or ligaments attach to the
bone and inflammation of the enthesis (enthesitis) is an
important and frequent manifestation of inflammatory
musculoskeletal disease, especially the Spondyloarthritis (SpA)
group of diseases, which includes ankylosing spondylitis (AS)
and psoriatic arthritis (PsA) (1–3). Plasmacytoid dendritic cells
(pDCs), are a rare immune cell subset that was first functionally
characterized in the late 1990s (4) that upon toll-like receptor
(TLR)-7 and TLR-9 stimulation, which recognize RNA and DNA
respectively, are known to secrete type-I interferons (IFN) and
other inflammatory cytokines such as TNF (5, 6). Moreover,
pDCs have been implicated in psoriasis immunopathology
whereby cutaneous pDCs orchestrate disease development
through IFNa induction culminating in psoriasis development
(4, 7, 8). Bacterial or viral infection or vaccinations have been
linked to PsA and SpA like disease (7, 9, 10).
The IL-17 axis and TNF cytokine pathways are central to the
pathogenesis of PsA and SpA, but the emerging JAK inhibition in
PsA and AS do not directly impact on the TNF/IL-17 pathways
(11). However, the JAK-STAT pathway is a critical regulator of
pDC cytokine production, including TNF and interferon.
Nevertheless, direct evidence for this pathway as a potential
human SpA initiator is lacking. During the global COVID-19
virus pandemic, arthralgia has been reported, raising the
possibility of a poorly defined entheseal mechanism (12, 13).
We previously found evidence for a population of entheseal
resident pDCs by phenotypic criteria (14). Herein, we
investigated immune responses of entheseal pDCs following
TLR7 and TLR9 stimulation and the potential modulation of
this response by emergent SpA therapeutics and also whether the
SARS-CoV-2 RNA virus, with potent TLR7 agonist properties
was associated with PsA disease flares.MATERIALS AND METHODS
Enthesis Samples
Normal interspinous process was obtained from 54 patients (20
men and 34 women; age 53.6 ± 23.2 years) who were undergoingorg 2spinal decompression or corrective scoliosis surgery. Peripheral
blood was also collected from these patients and healthy
volunteers (n=5). The enthesis was subsequently separated into
peri-entheseal bone (PEB) and the entheseal soft tissue (EST).
PEB was chosen for the following experiments because cells were
more numerous in PEB than in ST. Mononuclear cells were
isolated from PEB by mechanical digestion, as previously
indicated (14, 15). The study protocol of the current
investigation was approved by North West-Greater Manchester
West Research Ethics Committee.
Phenotyping of Entheseal pDC and
Intracellular Measurement of TNF
Following ODN or Imiquimod Stimulation
Following digestion, 5×106 PEB cells were incubated in RPMI
(Sigma-Aldrich) containing 10% FBS (Gibco) and 1% p/s
(Penicillin-Streptomycin). Cells were stimulated with CpG
oligodeoxynucleotides (ODN 2216, InvivoGen, 20 mg/mL) or
imiquimod (30 mM, Cayman Chemical) for 2 hr. Cells were
subsequently incubated for 12 hr in the presence of Golgi Plug
(BD Biosciences). Following this, cells were blocked in 10% mouse
serum and 1% human IgG buffer prior to incubation with
antibodies. Cells were then stained extra and intracellularly using
the Intraprep staining kit (Beckman Coulter) according to the
manufacturer’s protocol. Cells were stained using anti-CD45, CD3,
CD14, CD19, CD56, CD11c, HLA-DR, CD123, CD303 and TNF
(additional details on the antibodies and processes used available
upon request from the corresponding author). Cells were analyzed
using LSRII (BD Biosciences) and FlowJo software (Tree
Star Software).
Isolation of pDC and Tomographic
Microscopy
Following digestion, pDCs were selected using CD304 (BDCA-4)-
Biotin (Miotenyl Biotec, 2 ml per 10×10^6 cells) using LS columns
(Miotenyl Biotec) according to the manufacturer’s protocol. Cells
were subsequently separated into pDCs and non-pDCs. Isolated
entheseal pDCs were seeded into 35-mm tissue culture dish at
15,000 cells/dish. The dish was then placed on a holotomographic
microscope (3D Explorer, NanoLive, Lausanne, Switzerland)
equipped with a 60X objective, and images were taken
at ×600 magnification.April 2021 | Volume 12 | Article 635018
Zhou et al. Plasmacytoid Dendritic Cells in PsAStimulation of pDCs and Quantification
of IFNa by ODN
Due to sample size variance and resultant cell yields, different
pDC numbers were isolated and seeded per experiment (between
12000 and 50000 per well) with IFNa secretion being expressed
as pg/cell. During method optimization we noted that ODN was
a much more potent inducer of entheseal pDC IFNa production
than imiquimod (Supplementary Figure1B). Consequently,
further in vitro studies were carried out on ODN stimulated
cells whereby cells were stimulated with 20 mg/ml ODN for
24 hrs. Following this, supernatant was harvested. IFNa (all
isoforms) were measured using ELISA (PBL Assay Science). The
cells were harvested and RNA was isolated using PicoPure RNA
isolation kit (ThermoFisher) and complementary DNA was
synthesized using a high-capacity reverse transcription kit
(ThermoFisher). Quantitative real-time polymerase chain
reaction (PCR) with an ABI 7500 thermocycler (Applied
Biosystems) was performed to measure IFNa gene expression
using Taqman gene expression assay and universal Taqman
master mix (both Thermofisher). Expression levels of target
gene were calculated relative to expression of the housekeeping
gene HPRT1.
Antagonism of IFNa Secretion
After digestion, 1×105 cells/ml entheseal cells were seeded into
96-well plate. Cells were stimulated with ODN as before, with
and without tofacitinib 1 mM (Pfizer), PDE4i/Rolipram 100µM
(Cayman Chemical) or Methotrexate 5 mg/ml (Cayman
Chemical) for 24 hr. DMSO 0.1% served as a solvent control.
IFNa was quantified by ELISA as before.
Nanostring Analysis of Entheseal and
Blood pDCs Upon ODN Stimulation
Post ODN stimulation, RNA was extracted from enriched
entheseal pDCs and matched blood cells as described above
(each n=5). Immune related gene expression was assessed
using a predesigned human autoimmune profiling panel
established by Nanostring consisting of 770 immune related
(genes involved in autoimmune, chronic inflammatory, and
aberrant immune response diseases) and 20 housekeeping
genes. All RNA samples were quality controlled using
Nanodrop 8000. 100ng of total RNA from each sample was
used for setting up the NanoString probe PCR hybridization
(24 hrs) at 65°C. Following hybridization, excess probes were
removed using nCounter Prep Station and magnetic beads,
hybridized mRNA/probe were immobilized on a streptavidin-
coated cartridge. The processed cartridges were scanned using
an nCounter digital analyzer platform (nCounter® FLEX
Analysis System) for generation of the raw data with a high-
resolution scan (555 fov). Raw data were processed with
nSolver Analysis Software (V.4.0), imaging quality control
(QC), mRNA positive control QC and normalization QC
checked, and all the samples were within the quality
parameters of NanoString gene expression assays. Differential
gene expression analysis was performed using nSolver advance
analysis module V. 2.0.Frontiers in Immunology | www.frontiersin.org 3Bioinformatics Analysis
Nanostring data was analyzed using nSolver 4.0 and plot using
Graphpad 8.0. Log2|fold change| >1 and Benjamini-Yekutieli
p-value (FDR) <0.05 were considered statistically significant.
Protein-protein interaction (PPI) network was analyzed using
online STRING database (https://string-db.org/). Pathways
mapping was generated by ingenuity pathway analysis (IPA,
QIAGEN Inc.) (16). IPA was used to predicted possible upstream
regulators of the proteins in this study, which were assigned as
inhibited or activated according to Z-score, a statistical result of
differential gene expression according to the fold changes (17).
Enrichment is determined by significance overlap of genes
known to be in this pathway according to the knowledge base
and genes that are regulated in the dataset. Significance is
measured by Fisher exact test by p-value.
Assessment of Disease Flares in PsA
Post COVID-19 Infection
SARS-CoV2 virus is a single-stranded RNA virus that stimulates
TLR7 pathways. To provide further support for the potential
relevance of viral infection in SpA related disease, 18 PsA
patients (Classification Criteria for Psoriatic Arthritis
(CASPAR) score ≥3) with a confirmed COVID-19 diagnosis
by nasopharyngeal PCR were evaluated for PsA disease flare
between February and April 2020. The disease activity in
psoriatic arthritis (DAPSA) scores including swollen and
tender joints count, were collected at three times points: T0-
last most recent measurement before infection; T1-during
infection, whilst the patient was stable; T2-post infection,
following 2 negative nasopharyngeal specimen tests. Patient
demographic is reported in Table 1 (Supplementary Material).
Statistical Analysis
Statistical significance was calculated using 2-tailed paired t-test
unless stated. The analysis was performed using Prism software
(GraphPad Software8.0). Error bars represent the standard error
of the mean (SEM). p<0.05 was considered statistically significant.RESULTS
Human Entheseal pDCs Secrete TNF and
IFNa After ODN Stimulation
Following entheseal digestion, pDCs were confirmed in PEB by
flow cytometry by a CD45+HLA-DR+CD123+CD303+CD11c-
Lin- phenotype (Figure 1A) and morphology is shown in
Supplementary Figure 1A. Flow cytometry showed that pDCs
were more numerous in PEB than in peripheral blood (1.86 ±
0.77% vs 0.21 ± 0.07% among CD45+ cells, n=5, p=0.008, Figure
1B). Entheseal cells stimulated with ODN showed upregulation
of intracellular TNF (Figure 1A). TNF was also induced
following imiquimod stimulation as determined by
intracellular flow cytometry (n=4, Figure 1C).
Following isolation of both entheseal pDCs and non-pDCs
and subsequent ODN stimulation, basal IFNa transcripts were
detectable in unstimulated pDC (relative expression 1.552 ±April 2021 | Volume 12 | Article 635018
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ODN stimulation (relative expression 3.053 ± 1.070, p=0.01,
Figure 1D). At the protein level, IFNa was only detectable from
the pDC stimulated fraction (0.089 ± 0.038 pg/cell, p=0.031,
Figure 1E). Noting that total IFNa was secreted by entheseal
pDCs, further experiments were undertaken on unsorted cells.
We investigated the effect of SpA disease-relevant compounds
and their potential to modulate IFNa secretion. Both Tofacitinib
(0.003 ± 0.002 pg/cell, p=0.008) and PDE4i (0.008 ± 0.004 pg/
cell, p=0.002) significantly reduced ODN induced IFNa.
Methotrexate however, had no effect on IFNa production
(0.050 ± 0.016 pg/cell, p=0.24) (Figure 1F).
DEG Pattern of Stimulated Entheseal
pDCs and TNF Pathway
Following ODN stimulation of entheseal pDCs, using
NanoString, hierarchically clustered heat map representation of
global gene expression profiles showed that stimulated pDCs
could be differentiated from the unstimulated samples, although
heterogeneity might exist (Figure 2A). Eleven DEGs were
significantly upregulated in the stimulated pDCs, including
TNF (log2 fold change=1.95, p=0.042, Figure 2B). Protein-
protein interaction (PPI) network was constructed from the 11
DEGs including 4 isolated nodes and 1 main connection
component (Figure 2C). There were a total of 8 edgesFrontiers in Immunology | www.frontiersin.org 4identified and PPI enrichment p-value was 0.004. The main
component consisted of ZBP1, RIPK3, TNF, ITGB2 and TLR7.
RIPK3 and TNF had the greatest degree of interaction
(Figure 2C).
Canonical pathway analysis of the entheseal pDC genes upon
ODN stimulation using IPA showed that pathways related to
dendritic cell maturation (22 genes, z=4.416, p=1.59E-19,
Supplementary Figure 2), NF-kB signaling (19 genes, z=3.3,
p =5.5E-16, Supplementary Figure 3), toll-like receptor
signaling (14 gens, z=2.714, p=1.65E-15, Figure 2D) and JAK/
STAT signaling (8 genes, z= 2.828, p=3.05E-07, Figure 2E) were
significantly activated.
Increased DAPSA Following Sars-Cov-2
Infection
18 PsA patients with confirmed COVID-19 showed increased
DAPSA score following COVID-19 (Figure 3A, 9.7 ± 4.06 vs
35.3 ± 7.47 pre- and during infection, respectively, p<0.0001).
Even post-infection, DAPSA scores remained higher (Figure 3B,
9.7 ± 4.06 vs. 18.8 ± 4.39 for pre- and post-infection, respectively,
p<0.0001). With respect to swollen and tender joint count,
statistically significant increases were shown for both during
and post-infection (Figure 3C, 0.9 ± 0.9, 1.9 ± 0.8, 1.5 ± 0.6 for
pre-, during, and post-infection, respectively. P=0.0005 for
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We report the presence of an enriched pDC population at the
normal human enthesis. Upon relevant TLR pathway
stimulation, we demonstrated inducible TNF and IFNa protein
production and IPA analysis showed this operated through
NFkB or MYD88 pathways, respectively. The enthesis pDC
TNF induction by TLR7/9 is interesting since this is a critical
cytokine in enthesitis (18). Although TNF is produced by many
cells, pDCs was the sole entheseal source of TLR9 induced IFNa.
The pDCs production of type-I interferons is a quintessential
component of viral defense (19). Bacterial triggers are well
defined in reactive arthritis and in experimental SpA and a
role for viral infection is also reported in reactive arthritis and
several epidemiological surveys have shown a link between viral
triggers and PsA onset (20–22), but viral initiation is not
commonly thought of as important in axial disease including
in AS. In keeping with this, we report that SARS-CoV-2 infection
resulted in PsA disease flares. Also, pDCs have previously been
reported to be more abundant in PsA synovial fluid when
compared to osteoarthritis or rheumatoid arthritis (23, 24).
Blood pDCs are decreased in peripheral blood of PsA and
showed chemotaxis towards PsA synovial fluid (24).Frontiers in Immunology | www.frontiersin.org 5We also investigated several SpA and PsA disease relevant
compounds for their ability to modulate entheseal IFNa
induction. In agreement with previous blood derived pDC
studies, both PDE4i and Tofacitinib attenuated ODN induced
IFNa (25, 26); however, methotrexate did not. As TLR
stimulation does not directly signal via JAK-STAT pathway,
Tofacitinib attenuation of entheseal IFNa production could be
due to reduced pDC TLR mRNA receptor expression, thus
leading to decreased IFNa production as previously
reported (25).
The limitations of this study include the relatively small
sample numbers and the fact that functional analysis could
only be done on the spinous process peri-entheseal bone.
However, it still highlighted that upregulation of TNF and
IFNa in stimulated entheseal pDCs that could be blocked with
JAK and PDE4 inhibition. Studies of pDCs from sites of active
enthesitis would also be desirable. Second, the time length of
post-infection was different for each PsA patient so we cannot
use a specific time period to indicate how long symptoms
persisted after infection.
In conclusion, entheseal pDCs may represent a novel
population that bridges SpA enthesis immunopathology and
may be a population modified by JAK and PDE4 inhibitionA
B
D E FC
FIGURE 1 | (A) Peri-entheseal bone (PEB) was separated from soft tissue and digested and pDC phenotype was confirmed using flow cytometry. Following
stimulation with ODN, intracellular TNF was quantified using flow cytometry (last 2 graphs in A). (B) Flow cytometry showed that entheseal pDCs were more
numerous than blood pDCs (1.86 ± 0.77% vs 0.21 ± 0.07% of CD45+ cells, n=5, p=0.008). (C) Mean percentage increase of TNF MFI also showed a significant
increase after stimulation with imiquimod (18.03% vs 0.18%, n=4, p=0.047). Secretion of IFNa from pDCs after ODN stimulation was demonstrated by RT-PCR
(n=8, D) and ELISA (n=6, E) respectively. The effect of different drugs on the expression of IFNa from entheseal cells was compared (n=4, F). IFNa from ODN
stimulated: 0.035 ± 0.011 pg/cell, co-incubated with Tofacitinib: 0.003 ± 0.003 pg/cell, co-incubated with PED4i: 0.008 ± 0.008 pg/cell, co-incubated with MTX:
0.050 ± 0.031 pg/cell. LIN: lineage markers (CD3, CD56, CD19, CD14, CD11c), MFI, median fluorescence intensity; IMQ, imiquimod; Unstim, unstimulated; stim,
stimulated. *p < 0.05, **p < 0.01.April 2021 | Volume 12 | Article 635018
Zhou et al. Plasmacytoid Dendritic Cells in PsAand also provides a novel mechanistic link between infection,
including viral triggers and SpA associated arthropathies.
Numerical and functional abnormalities have already beenFrontiers in Immunology | www.frontiersin.org 6reported in other rheumatic diseases including systemic lupus
erythematosus and rheumatoid arthritis but this is the first study




FIGURE 2 | (A) Heatmap showing clustering of PEB stimulated pDCs and PEB unstimulated pDCs. (B) Volcano map showing 11 significantly upregulated genes
(red, Log2(fold change) >1 and p<0.05) in stimulated vs unstimulated entheseal pDCs. Gene symbols were displayed if Log2|fold change| > 1. (C) PPI network of the
11 DEGs showing a main component consisted and 4 isolated nodes. Lines connecting two nodes represent protein-protein associations. Pathway mapping
analysis of pDCs generated by IPA revealed the toll-like receptor signaling (D) and JAK/STAT signaling (E) among the topmost canonical pathways enriched upon
treatment with ODN. Stimulation of TLRs leads to activation of MYD88 and finally transcription of pro-inflammatory cytokines including TNF (D). Activation of JAK
leads to activation of STAT or PI3K pathway, which is predicted by IPA (E). Prediction legend is shared by 2D and 2E. Red & pink represents upregulation and
intensity represents the relative magnitude of change in gene expression. Predicted activation indicated by orange color and blue for the predicted inhibition. Direct
and indirect interactions are indicated by solid and dashed lines, respectively.April 2021 | Volume 12 | Article 635018
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